ASCO GU 2020: Five-year survival data for metastatic kidney cancer patients treated with nivolumab
Five-year follow-up results from the phase 3 CheckMate-025 study, which [...]
Molecular genetics of renal cell carcinoma
Most renal cell carcinomas (RCC) are diagnosed from studying the [...]
Universal active surveillance for small renal masses
A study presented at the Society of Urologic Oncology (SUO) [...]
Is there a role for cytoreductive nephrectomy?
This discussion with Dr Paul Russo presents a case for [...]
Despite promising new regimens, search for cure is ‘highest priority’ in advanced renal cell carcinoma
This review, published in HemOnc Today this week, discusses the [...]
SMC approves nivolumab plus ipilimumab combination for advanced RCC
We are delighted to announce that the Scottish Medicines Consortium [...]
ASCO 2019: Biomarkers for advanced renal cell carcinoma from the JAVELIN Renal 101 study
Results from the biomarker analysis from the JAVALIN Renal 101 [...]
Complete response of kidney cancer brain metastases to cabozantinib
A recent case study, reported in Case Reports in Urology, [...]
Potential urine biomarkers for small renal masses
A recent study, published in the International Journal of Urology, [...]
Sources of frustration for patients with kidney cancer
This observation study involved 450 patients with renal cell carcinoma [...]
